| Bioactivity | XH02 is a compound based on L6 modification. XH02 (177Lu labeled) displays exceptional tumor growth inhibition in BxPC-3 tumors[1]. |
| Formula | C137H212F3N33O41 |
| Molar Mass | 3034.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yang B, et al. 177Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy. J Med Chem. 2025 Feb 13;68(3):3146-3156. |